Discover 162 paid clinical trials in Augusta, Maine. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 162
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Augusta ME, Brewer ME, Methuen MA, Boston MA,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Portland ME, Albany NY, Waterbury CT, Mount Kisco NY,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Active & Responsive
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
for
Mitral Valve Regurgitation
Location: Portland ME, Lebanon NH, Boston MA, Quebec, Ottawa,
Sponsor: Annetine Gelijns
Sex: All
Age: 60+
Code: NCT05051033
Recruiting
New
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Scarborough ME, Bangor ME, Lebanon NH, Boston MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase3, Recruiting
Training and Implementation of RUBI in Community Mental Health Settings
for
Autism Spectrum Disorder
Location: Augusta ME
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0+
Code: NCT05742464
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
for
Immunoglobulin A Nephropathy, IgAN
Location: Augusta ME, Boston MA, Albany NY, East Setauket NY,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06291376
Phase3, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Augusta ME, South Portland ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
for
Stage III Cutaneous Melanoma AJCC v7,
Location: Augusta ME, Boston MA, Springfield MA, Hartford CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT02339571
Phase2, Phase3, Recruiting
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
for
Recurrent Endometrial Carcinoma,
Location: Augusta ME, Scarborough ME, Brewer ME, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05554328
Phase2, Recruiting
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Augusta ME, Concord NH, Montpelier VT, Boston MA,